Capillary gel electrophoresis: A simple method for identification of mutations and polymorphisms in the CEBPA gene in patients with acute myeloid leukaemia

European Journal of Haematology

Volumn 81, Issue 4, 2008, Pages 273-280

  Juhl Christensen, Caroline ^a   Bomberg, Marianne ^a   Melsvik, Dorte ^a   Hokland, Peter ^a   Nyvold, Charlotte Guldborg ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Acute myeloid leukaemia; Capillary gel electrophoresis; CEBPA; PCR

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BONE MARROW; CONTROLLED STUDY; DNA POLYMORPHISM; GEL ELECTROPHORESIS; GENE DELETION; GENE IDENTIFICATION; GENE INSERTION; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

CAPILLARY ELECTROCHROMATOGRAPHY; CCAAT-ENHANCER-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MUTATION; MYELOID PROGENITOR CELLS; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES;

EID: 51649084873     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2008.01117.x     Document Type: Article

References (31)

1. Gilliland DG. Hematologic malignancies. Curr Opin Hematol 2001 8 : 189 91.
2. Jaffe ES, Harris NL, Stein H, Vardiman JW Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. France : IARC Press/WHO, 2001.
3. Grimwade D, Walker H, Oliver F, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. Blood 1998 92 : 2322 33.
4. Mrozek K, Marcucci G, Paschka P, Whitman SP, Bloomfield CD. Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification? Blood 2007 109 : 431 48.
5. Schuster M, Porse B. C/EBPα: a tumour suppressor in multiple tissues? Biochim Biophys Acta Rev Cancer 2006 1766 : 88 103.
6. Pabst T, Mueller BU, Harakawa N, et al. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia. Nat Med 2001 7 : 444 51.
7. Zheng R, Friedman AD, Levis M, Li L, Weir EG, Small D. Internal tandem duplication mutation of FLT3 blocks myeloid differentiation through suppression of C/EBP{alpha} expression. Blood 2004 103 : 1883 90.
8. Radomska HS, Basseres DS, Zheng R, et al. Block of C/EBP{alpha} function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations. J Exp Med 2006 203 : 371 81.
9. Frohling S, Dohner H. Disruption of C/EBP{alpha} function in acute myeloid leukemia. N Engl J Med 2004 351 : 2370 72.
10. Preudhomme C, Sagot C, Boissel N, et al. Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA). Blood 2002 100 : 2717 23.
11. Leroy H, Roumier C, Huyghe P, Biggio V, Fenaux P, Preudhomme C. CEBPA point mutations in hematological malignancies. Leukemia 2005 19 : 329 34.
12. Lin L, Lin T, Chou W, Tang J, Lin D, Tien H. A novel fluorescence-based multiplex PCR assay for rapid simultaneous detection of CEBPA mutations and NPM mutations in patients with acute myeloid leukemias. Leukemia 2006 20 : 1899 903.
13. Frohling S, Schlenk RF, Stolze I, et al. CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations. J Clin Oncol 2004 22 : 624 33.
14. Ballard L, Adams P, Bao Y, et al. Strategies for genotyping: effectiveness of tailing primers to increase accuracy in short tandem repeat determinations. J Biomol Tech 2002 13 : 20 29.
15. Resende C, Regalo G, Duraes C, Carneiro F, Machado JC. Genetic changes of CEBPA in cancer: mutations or polymorphisms? J Clin Oncol 2007 25 : 2493 4.
16. Lin LI, Chen CY, Lin DT, et al. Characterization of CEBPA mutations in acute myeloid leukemia: most patients with CEBPA mutations have biallelic mutations and show a distinct immunophenotype of the leukemic cells. Clin Cancer Res 2005 11 : 1372 9.
17. Wouters BJ, Louwers I, Valk PJM, Lowenberg B, Delwel R. A recurrent in-frame insertion in a CEBPA transactivation domain is a polymorphism rather than a mutation that does not affect gene expression profiling-based clustering of AML. Blood 2007 109 : 389 90.
18. Liang DC, Shih LY, Huang CF, et al. CEBPalpha mutations in childhood acute myeloid leukemia. Leukemia 2005 19 : 410 14.
19. Wang H, Iakova P, Wilde M, et al. C/EBPα arrests cell proliferation through direct inhibition of Cdk2 and Cdk4. Mol Cell 2001 8 : 817 28.
20. Weinberg RA Tumor Suppressor Genes. The Biology of Cancer 270 New York, NY, USA : Garland Science, 2006 : 209 210 254.
21. Pabst T, Mueller BU, Zhang P, et al. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-[alpha] (C/EBP[alpha]), in acute myeloid leukemia. Nat Genet 2001 27 : 263 70.
22. Mueller BU, Pabst T. C/EBPalpha and the pathophysiology of acute myeloid leukemia. Curr Opin Hematol 2006 13 : 7 14.
23. Fuchs O, Provaznikova D, Kocova M, et al. CEBPA polymorphisms and mutations in patients with acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin's lymphoma. Blood Cells Mol Dis 2008 40 : 401 5.
24. Benthaus T, Mellert G, Zellmeier E, et al. A rapid and sensitive method for large-scale screening of CEBPA mutations in AML patients with normal karyotype. American Society of Hematology, Annual Meeting 2007;Abstract no.:3483.
25. Gombart AF, Hofmann W, Kawano S, et al. Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias. Blood 2002 99 : 1332 40.
26. Snaddon J, Smith ML, Neat M, et al. Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2. Genes Chromosomes Cancer 2003 37 : 72 8.
27. Bienz M, Ludwig M, Mueller BU, et al. Risk assessment in patients with acute myeloid leukemia and a normal karyotype. Clin Cancer Res 2005 11 : 1416 24.
28. Frohling S, Schlenk RF, Krauter J, et al. Acute myeloid leukemia with deletion 9q within a noncomplex karyotype is associated with CEBPA loss-of-function mutations. Genes Chromosomes Cancer 2005 42 : 427 32.
29. Shih L, Liang D, Huang C, et al. AML patients with CEBP[alpha] mutations mostly retain identical mutant patterns but frequently change in allelic distribution at relapse: a comparative analysis on paired diagnosis and relapse samples. Leukemia 2006 20 : 604 609.
30. den Dunnen JT, Antonarakis SE Recommendations for the descriptions of sequence variants. 2007 Available at: http://www3.interscience.wiley.com/cgi- bin/fulltext/68503056/PDFSTART. Accessed 2008-01-03, 2008.
31. Barjesteh van Waalwijk van Doorn-Khosrovani S, Erpelinck C, Meijer J, et al. Biallelic mutations in the CEBPA gene and low CEBPA expression levels as prognostic markers in intermediate-risk AML. Hematol J 2003 4 : 31 40.